Fosun Health Capital
VC Fund
Xuhui, China
Fosun Health Capital is a VC fund in Xuhui focused on Medical and Health Care. Fujian Capital New Drug Innovation Fund is the first new drug innovation fund mainly based on the holding incubation model
- Total investments:
- 19
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Fosun Health Capital invests in
Stages Fosun Health Capital invests in
Countries Fosun Health Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jin Bi
|
|||
|
Li Fan
|
|||
Investment Focus
Industry
- Medical 7 (37%)
- Health Care 5 (26%)
- Biotechnology 5 (26%)
- Pharmaceutical 4 (21%)
- Biopharma 3 (16%)
Stage
- Seed 5 (26%)
- Series A 4 (21%)
- Angel 3 (16%)
- Series B 3 (16%)
- Series C 3 (16%)
Country
- China 14 (74%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jin Bi
Executive General Manager
|
Executive General Manager | Total investments: 1 | Find email | |
|
Li Fan
CEO
|
CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
BrainThink Technology
|
BrainThink Technology is a high-tech enterprise specializing in the research and development of brain-computer interface (BCI) technology. | $10M / Angel / May 18, 2026 | |
Fosun Kite Biotechnology
|
Fosun Kite Biotechnology develops immune cell therapy products. Fosun Kite Biotechnology is a joint venture of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, and U.S. Kite Pharma. | $84.2M / Series A / Oct 17, 2025 | |
InxMed
|
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $34M / Series C / Aug 22, 2025 | |
|
Hengtai Bio
|
Hengtai Bio is a biotechnology company focused on pharmaceutical manufacturing, specializing in the research, development, and large-scale production of high-quality pharmaceutical products. | Angel / Aug 07, 2025 | |
Cellbri
|
Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs. | Series B / Mar 27, 2025 | |
Celregen Therapeutics
|
Celregen Therapeutics is a pharmaceutical business that focuses on the development of novel medications in the domains of cell therapy and regenerative medicine. | $13.8M / Angel / Mar 18, 2025 | |
Transcend Vivoscope
|
Transcend Vivoscope is a biotechnology company that specializes in providing advanced microscopy imaging products and solutions. | Series B / Feb 12, 2025 | |
Aiyi animal medicine
|
Aiyi Animal Medicine develops and produces veterinary biological products and veterinary chemical medications. | $13.7M / Series C / Jan 06, 2025 | |
|
Jishi Medical
|
Jishi Medical is a med-tech company that specializes in the research and development of eye diseases and overall solutions for ophthalmology diagnosis and treatment. | Seed / Nov 08, 2024 | |
|
Celregen Therapeutics
|
Celregen Therapeutics is a pharmaceutical business that focuses on the development of novel medications in the domains of cell therapy and regenerative medicine. | Seed / Sep 14, 2024 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Fosun Health Capital invest in?
Fosun Health Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fosun Health Capital?
Public channels for Fosun Health Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fosun Health Capital?
The team at Fosun Health Capital includes Jin Bi (Executive General Manager) and Li Fan (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
